Crossmark

Major adverse cardiovascular events among patients with type-2 diabetes, a nationwide cohort study comparing primary metabolic and bariatric surgery to GLP-1 receptor agonist treatment

Crossref DOI link: https://doi.org/10.1038/s41366-023-01254-z

Published Online: 2023-01-20

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stenberg, Erik https://orcid.org/0000-0001-9189-0093
Näslund, Erik https://orcid.org/0000-0002-0166-6344
License Information

Text and Data Mining valid from 2023-01-20

Version of Record valid from 2023-01-20
More Information

Article History

Received: 25 October 2022

Revised: 31 December 2022

Accepted: 4 January 2023

First Online: 20 January 2023

Competing interests

: ES has received lecturing fees from Johnson & Johnson Medical.

: The study was approved by the National Ethics Board in Sweden (Ref: 2020–03005) and conducted in accordance with the standards of the 1964 Helsinki Declaration and its later amendments.

Document is current

Any future updates will be listed below